12/24
07:01 pm
amgn
Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity? [Yahoo! Finance]
Neutral
Report
Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity? [Yahoo! Finance]
12/22
04:36 pm
amgn
Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers [Yahoo! Finance]
Low
Report
Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers [Yahoo! Finance]
12/19
02:35 pm
amgn
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS [Yahoo! Finance]
Low
Report
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS [Yahoo! Finance]
12/19
02:23 pm
amgn
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
Low
Report
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
12/17
02:42 pm
amgn
HSBC Turns More Bullish on Amgen (AMGN) into 2026 [Yahoo! Finance]
Low
Report
HSBC Turns More Bullish on Amgen (AMGN) into 2026 [Yahoo! Finance]
12/16
04:21 am
amgn
Exploring Growth Trends in the Chemotherapy Induced Anemia Market: A Surge to USD 4.84 Billion by 2032 [Yahoo! Finance]
Low
Report
Exploring Growth Trends in the Chemotherapy Induced Anemia Market: A Surge to USD 4.84 Billion by 2032 [Yahoo! Finance]
12/15
01:13 am
amgn
Low
Report
12/12
07:05 pm
amgn
FDA Approves Amgen's UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease [Yahoo! Finance]
Low
Report
FDA Approves Amgen's UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease [Yahoo! Finance]
12/12
12:01 pm
amgn
Amgen (NASDAQ:AMGN) was given a new $304.00 price target on by analysts at Morgan Stanley.
Low
Report
Amgen (NASDAQ:AMGN) was given a new $304.00 price target on by analysts at Morgan Stanley.
12/11
06:53 pm
amgn
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS [Yahoo! Finance]
Low
Report
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS [Yahoo! Finance]
12/11
06:09 pm
amgn
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
Low
Report
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
12/10
09:16 am
amgn
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Wells Fargo & Company from $300.00 to $325.00. They now have an "equal weight" rating on the stock.
Low
Report
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Wells Fargo & Company from $300.00 to $325.00. They now have an "equal weight" rating on the stock.
12/10
07:21 am
amgn
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at HSBC Holdings plc.
Low
Report
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at HSBC Holdings plc.
12/9
04:58 pm
amgn
Amgen raises dividend by ~6% [Seeking Alpha]
Low
Report
Amgen raises dividend by ~6% [Seeking Alpha]
12/9
04:25 pm
amgn
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND [Yahoo! Finance]
Low
Report
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND [Yahoo! Finance]
12/9
04:01 pm
amgn
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND
Low
Report
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND
12/7
01:05 am
amgn
Low
Report
12/5
10:05 am
amgn
Amgen (NASDAQ:AMGN) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
Low
Report
Amgen (NASDAQ:AMGN) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
12/3
05:15 pm
amgn
Amgen Inc. (AMGN) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Amgen Inc. (AMGN) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/3
08:05 am
amgn
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Low
Report
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
12/2
03:00 am
amgn
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Globe and Mail, The (Toronto, Canada)]
Low
Report
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Globe and Mail, The (Toronto, Canada)]
12/2
02:13 am
amgn
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Yahoo! Finance]
Low
Report
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Yahoo! Finance]
11/29
11:43 pm
amgn
Is Amgen's Recent Rally Justified After Strong Clinical Trial Results? [Yahoo! Finance]
Low
Report
Is Amgen's Recent Rally Justified After Strong Clinical Trial Results? [Yahoo! Finance]
11/29
03:35 am
amgn
Low
Report
11/25
07:37 pm
amgn
IMDELLTRA's FDA Approval and Guideline Upgrade Could Be a Game Changer for Amgen (AMGN) [Yahoo! Finance]
Low
Report
IMDELLTRA's FDA Approval and Guideline Upgrade Could Be a Game Changer for Amgen (AMGN) [Yahoo! Finance]